company background image
ZOTA logo

Zota Health Care NSEI:ZOTA Stock Report

Last Price

₹474.50

Market Cap

₹11.9b

7D

1.3%

1Y

64.6%

Updated

28 Mar, 2024

Data

Company Financials

Zota Health Care Limited

NSEI:ZOTA Stock Report

Market Cap: ₹11.9b

ZOTA Stock Overview

Zota Health Care Limited develops, manufactures, and markets pharmaceutical products in India and internationally.

ZOTA fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends0/6

Zota Health Care Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Zota Health Care
Historical stock prices
Current Share Price₹474.50
52 Week High₹555.00
52 Week Low₹270.00
Beta0.64
1 Month Change-10.68%
3 Month Change0.43%
1 Year Change64.61%
3 Year Change227.58%
5 Year Change152.49%
Change since IPO351.75%

Recent News & Updates

Recent updates

Zota Health Care (NSE:ZOTA) Has Re-Affirmed Its Dividend Of ₹1.00

Sep 20
Zota Health Care (NSE:ZOTA) Has Re-Affirmed Its Dividend Of ₹1.00

Zota Health Care (NSE:ZOTA) Has Announced A Dividend Of ₹1.00

Sep 04
Zota Health Care (NSE:ZOTA) Has Announced A Dividend Of ₹1.00

Are Dividend Investors Getting More Than They Bargained For With Zota Health Care Limited's (NSE:ZOTA) Dividend?

Mar 25
Are Dividend Investors Getting More Than They Bargained For With Zota Health Care Limited's (NSE:ZOTA) Dividend?

What Type Of Returns Would Zota Health Care's(NSE:ZOTA) Shareholders Have Earned If They Purchased Their SharesYear Ago?

Jan 19
What Type Of Returns Would Zota Health Care's(NSE:ZOTA) Shareholders Have Earned If They Purchased Their SharesYear Ago?

Zota Health Care Limited's (NSE:ZOTA) Has Been On A Rise But Financial Prospects Look Weak: Is The Stock Overpriced?

Dec 15
Zota Health Care Limited's (NSE:ZOTA) Has Been On A Rise But Financial Prospects Look Weak: Is The Stock Overpriced?

Shareholder Returns

ZOTAIN PharmaceuticalsIN Market
7D1.3%2.4%1.8%
1Y64.6%65.8%48.6%

Return vs Industry: ZOTA matched the Indian Pharmaceuticals industry which returned 63.9% over the past year.

Return vs Market: ZOTA exceeded the Indian Market which returned 47.3% over the past year.

Price Volatility

Is ZOTA's price volatile compared to industry and market?
ZOTA volatility
ZOTA Average Weekly Movement5.1%
Pharmaceuticals Industry Average Movement5.9%
Market Average Movement6.6%
10% most volatile stocks in IN Market10.1%
10% least volatile stocks in IN Market4.0%

Stable Share Price: ZOTA has not had significant price volatility in the past 3 months.

Volatility Over Time: ZOTA's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1995338Sujit Paulhttps://www.zotahealthcare.com

Zota Health Care Limited develops, manufactures, and markets pharmaceutical products in India and internationally. It offers generic drugs, over-the-counter products, ayurvedic products, and nutraceutical products. The company provides various medicines for chronic illnesses, including diabetes, heart conditions, and thyroid disorders.

Zota Health Care Limited Fundamentals Summary

How do Zota Health Care's earnings and revenue compare to its market cap?
ZOTA fundamental statistics
Market cap₹11.94b
Earnings (TTM)-₹100.65m
Revenue (TTM)₹1.68b

7.1x

P/S Ratio

-118.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ZOTA income statement (TTM)
Revenue₹1.68b
Cost of Revenue₹948.36m
Gross Profit₹736.60m
Other Expenses₹837.25m
Earnings-₹100.65m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-4.00
Gross Margin43.72%
Net Profit Margin-5.97%
Debt/Equity Ratio49.4%

How did ZOTA perform over the long term?

See historical performance and comparison

Dividends

0.2%

Current Dividend Yield

-44%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.